Open-Label Exploratory Investigation of D-Cycloserine Augmentation to Cognitive Behavioral Therapy With Exposure and Response Prevention for Adults and Adolescents Diagnosed With Obsessive Compulsive Disorder - A Feasibility Study.

Trial Profile

Open-Label Exploratory Investigation of D-Cycloserine Augmentation to Cognitive Behavioral Therapy With Exposure and Response Prevention for Adults and Adolescents Diagnosed With Obsessive Compulsive Disorder - A Feasibility Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2014

At a glance

  • Drugs Cycloserine (Primary)
  • Indications Obsessive-compulsive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Dec 2013 Actual patient number (16) as reported by ClinicalTrials.gov record.
    • 01 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top